DJIA 17,712.66 34.43 0.19%
NASDAQ 4,891.22 27.86 0.57%
S&P 500 2,061.02 4.87 0.24%
market minute promo

Amicus Therapeutics, Inc. (NASDAQ: FOLD)

10.94 0.27 (2.53%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

FOLD $10.94 2.53%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $10.73
Previous Close $10.67
Daily Range $10.72 - $11.20
52-Week Range $1.77 - $13.20
Market Cap $1.0B
P/E Ratio -11.47
Dividend (Yield) $0.00 (0.0%)
Volume 1,547,117
Average Daily Volume 2,336,831
Current FY EPS -$1.10




Drug Makers

Amicus Therapeutics, Inc. (FOLD) Description

A clinical-stage biopharmaceutical company, which focused on the discovery, development and commercialization of novel small molecule, orally-administered drugs, known as pharmacological chaperones, for the treatment of a range of human genetic diseases. Website:

News & Commentary Rss Feed

In Case You Missed It, This Tiny Biotech Is Poised for Explosive Growth

Amicus Therapeutics, Inc. plans to file its drug for Fabry disease with EU and U.S. regulators soon.

Amicus Therapeutics Slumps: FOLD Falls 6.8% in Session - Tale of the Tape

Amicus to Seek for Migalastat's Approval in the U.S., EU - Analyst Blog

Amicus Therapeutics (FOLD) Highlighted As Today's Perilous Reversal Stock

Thursday Sector Leaders: Biotechnology, Drugs

Thursday's ETF Movers: XBI, ILF

Why Amicus Therapeutics, Inc. Stock Is Soaring Today

Shares of the rare disease drugmaker Amicus Therapeutics ripped higher by more than 30% today. Here's why.

Amicus Therapeutics (FOLD) Stock Spikes Today Following Accelerated Approval Filing Plan

Benzinga's Volume Movers

Morning Market Gainers

See More FOLD News...

FOLD's Top Competitors

FOLD $10.94 (2.53%)
Current stock: FOLD
AMGN $162.59 (1.27%)
Current stock: AMGN
GILD $101.00 (-0.07%)
Current stock: GILD
BIIB $429.87 (0.22%)
Current stock: BIIB